Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
